HK$95.15+9.75% · 3M
Moving avg
1W+0.32%
1M-1.96%
3M+16.04%
6M+7.39%
YTD+20.75%
1Y-0.89%
3Y+193.67%
5Y+31.70%
52-week range
$8.8665% of range$13.90
Company health
Value0/6
Growth3/6
Profitability4/6
Health6/6
Dividend0/6
Bull vs bear
Strengths
- High return on equity (482%)
- Revenue compounding 95% a year
- Net cash on the balance sheet
Risks
- Richly valued at 151.2x earnings
Key statistics
Valuation
Market cap
$21.11B
Enterprise value
$14.85B
P/E ratio (TTM)
151.19x
P/S ratio (TTM)
10.05x
EV/EBITDA
88.93x
Per share & returns
EPS (TTM)
$0.06
Dividend yield
0.00%
Beta (1Y)
0.23
30-day change
-1.96%
Trading
Volume (24h)
11.79M
Previous close
HK$95.55
Shares outstanding
1.74B
About Innovent Biologics, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
HKEX
Symbol
1801.HK
Innovent Biologics, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on HKEX (China) and trade under the ticker 1801.HK.
Frequently asked questions
What is Innovent Biologics, Inc.'s market cap?
Innovent Biologics, Inc. (1801.HK) has a market capitalization of $21.11B.
What is Innovent Biologics, Inc.'s P/E ratio?
Innovent Biologics, Inc. trades at a price-to-earnings (P/E) ratio of 151.19.
What exchange does 1801.HK trade on?
1801.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap